![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1271, 2009-01, pp. : 21-22
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab: Cutaneous leishmaniasis: case report
Reactions Weekly, Vol. 1, Iss. 1299, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adalimumab/infliximab: Cutaneous leishmaniasis: case report
Reactions Weekly, Vol. 1, Iss. 1187, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab: Visceral leishmaniasis: case report
Reactions Weekly, Vol. 1, Iss. 1091, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab: Visceral leishmaniasis: case report
Reactions Weekly, Vol. 1, Iss. 1209, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adalimumab: Cutaneous leishmaniasis: case report
Reactions Weekly, Vol. 1, Iss. 1274, 2009-01 ,pp. :